Literature DB >> 8200929

Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. Cooperative Study Group of Pubertal development in Chronic Renal Failure.

F Schaefer1, J D Veldhuis, R Stanhope, J Jones, K Schärer.   

Abstract

To elucidate the endocrine mechanisms underlying the pubertal growth failure observed in patients with chronic renal failure (CRF), we used deconvolution analysis to estimate the rates of GH secretion and elimination in nighttime plasma GH profiles of peripubertal boys with CRF and after renal transplantation (Tx). Forty-three boys with advanced CRF (conservative treatment with glomerular filtration rate < 25 mL/min.1.73 m2 or dialysis; CT/D group), 38 boys after Tx, and 40 healthy control boys were studied. The estimated plasma GH half-life (mean +/- SEM) was significantly higher (P < 0.05) in CRF (25 +/- 1.8 min) than in Tx patients (21 +/- 1.6 min) and controls (20 +/- 0.5 min). In the pre- and early pubertal CT/D boys, the calculated GH secretion rate was low normal or reduced when expressed in absolute numbers or normalized per unit distribution volume or body surface. In late puberty, whereas body surface-corrected GH secretion was double the prepubertal value in normal boys (389 +/- 56 vs. 868 +/- 113 micrograms/m2.11 h; P < 0.01), it did not differ significantly from the prepubertal rate in CT/D boys (281 +/- 59 vs. 389 +/- 56 micrograms/m2.11 h). GH hyposecretion resulted from a decrease in the mass of GH released within each burst, whereas burst frequency was unchanged. In the Tx group, GH secretion rates were significantly reduced in the prepubertal (221 +/- 39 micrograms/m2.11 h; P < 0.05) and late pubertal period (266 +/- 64 micrograms/m2.11 h; P < 0.01). The mass of hormone secreted per burst was significantly reduced at each pubertal stage, whereas GH secretory burst frequency tended to be increased (significant in prepubertal group, P < 0.05). The GH secretion rate was positively correlated with plasma testosterone levels (r = 0.58; P < 0.0001) in controls, but not in CT/D or Tx patients. GH secretion rates were lower than expected at each level of plasma testosterone in both patient groups except CT/D boys with plasma testosterone below 0.9 nmol/L. In the Tx group, GH secretion rate was positively correlated with relative height (r = 0.31; P < 0.05). The dosage of corticosteroids administered for immunosuppression was negatively correlated with GH burst mass (r = -0.42; P < 0.01) and GH secretion rate (r = -0.29; P = 0.08) and positively correlated with GH burst frequency (r = 0.49; P < 0.01). We conclude that in peripubertal boys with CRF, a state of GH hyposecretion is associated with an increase in the apparent plasma half-life of GH.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200929     DOI: 10.1210/jcem.78.6.8200929

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Adult height in patients with advanced CKD requiring renal replacement therapy during childhood.

Authors:  Jérôme Harambat; Marjolein Bonthuis; Karlijn J van Stralen; Gema Ariceta; Nina Battelino; Anna Bjerre; Timo Jahnukainen; Valérie Leroy; György Reusz; Ana R Sandes; Manish D Sinha; Jaap W Groothoff; Christian Combe; Kitty J Jager; Enrico Verrina; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

Review 2.  Nutrition and growth in children with chronic kidney disease.

Authors:  Lesley Rees; Robert H Mak
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

3.  Growth in boys with idiopathic nephrotic syndrome on long-term cyclosporin and steroid treatment.

Authors:  Valérie Leroy; Véronique Baudouin; Corinne Alberti; Geneviève Guest; Patrick Niaudet; Chantal Loirat; Georges Deschenes; Paul Czernichow; Dominique Simon
Journal:  Pediatr Nephrol       Date:  2009-08-11       Impact factor: 3.714

Review 4.  The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.

Authors:  Robert H Mak; Wai W Cheung; Charles T Roberts
Journal:  Growth Horm IGF Res       Date:  2007-09-07       Impact factor: 2.372

5.  Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease.

Authors:  Oleh Akchurin; Angara Sureshbabu; Steve B Doty; Yuan-Shan Zhu; Edwin Patino; Susanna Cunningham-Rundles; Mary E Choi; Adele Boskey; Stefano Rivella
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-20

Review 6.  Pubertal development in children with chronic kidney disease.

Authors:  Dieter Haffner; Miroslav Zivicnjak
Journal:  Pediatr Nephrol       Date:  2016-07-27       Impact factor: 3.714

Review 7.  Neuroendocrine adaptations in renal disease.

Authors:  Reinhard Feneberg; Franz Schaefer; Johannes D Veldhuis
Journal:  Pediatr Nephrol       Date:  2003-05-01       Impact factor: 3.714

Review 8.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

9.  Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone.

Authors:  Stefano Picca; Marco Cappa; Chiara Martinez; Seyoum Ido Moges; John Osborn; Francesco Perfumo; Gianluigi Ardissino; Roberto Bonaudo; Giovanni Montini; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

Review 10.  Growth hormone binding protein and free growth hormone in chronic renal failure.

Authors:  G Baumann
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.